Hood River Capital Management LLC bought a new position in shares of Catalent Inc (NYSE:CTLT) during the 4th quarter, HoldingsChannel reports. The fund bought 396,385 shares of the company’s stock, valued at approximately $16,283,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CTLT. 361 Capital LLC lifted its stake in shares of Catalent by 18.6% in the third quarter. 361 Capital LLC now owns 70,022 shares of the company’s stock valued at $2,795,000 after buying an additional 10,974 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in shares of Catalent by 25.2% in the third quarter. Schwab Charles Investment Management Inc. now owns 1,046,417 shares of the company’s stock valued at $41,773,000 after buying an additional 210,296 shares in the last quarter. Stevens Capital Management LP bought a new position in shares of Catalent in the third quarter valued at $2,475,000. Sei Investments Co. lifted its stake in shares of Catalent by 119.1% in the third quarter. Sei Investments Co. now owns 94,216 shares of the company’s stock valued at $3,761,000 after buying an additional 51,212 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust bought a new position in shares of Catalent in the third quarter valued at $18,420,000. 99.82% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Uwe Roehrhoff acquired 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The stock was acquired at an average price of $39.22 per share, for a total transaction of $294,150.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John R. Chiminski sold 181,458 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $39.62, for a total transaction of $7,189,365.96. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Shares of Catalent Inc (NYSE CTLT) opened at $40.47 on Monday. The company has a market cap of $5,395.41, a PE ratio of 25.29, a PEG ratio of 2.32 and a beta of 1.47. The company has a quick ratio of 1.78, a current ratio of 2.22 and a debt-to-equity ratio of 2.66. Catalent Inc has a 1-year low of $27.48 and a 1-year high of $47.87.

Catalent (NYSE:CTLT) last announced its earnings results on Monday, February 5th. The company reported $0.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.10. The company had revenue of $606.30 million during the quarter, compared to the consensus estimate of $565.05 million. Catalent had a net margin of 3.03% and a return on equity of 23.85%. The firm’s revenue for the quarter was up 25.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.27 earnings per share. sell-side analysts expect that Catalent Inc will post 1.53 EPS for the current year.

A number of research firms have weighed in on CTLT. Goldman Sachs Group began coverage on shares of Catalent in a research note on Wednesday, January 24th. They issued a “buy” rating and a $50.00 price objective on the stock. Royal Bank of Canada set a $48.00 price objective on shares of Catalent and gave the company a “buy” rating in a research note on Monday, February 5th. Stephens downgraded shares of Catalent from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 6th. Zacks Investment Research upgraded shares of Catalent from a “hold” rating to a “buy” rating and set a $48.00 target price for the company in a report on Wednesday, January 17th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Catalent in a report on Monday, October 23rd. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $45.60.

COPYRIGHT VIOLATION NOTICE: “396,385 Shares in Catalent Inc (CTLT) Acquired by Hood River Capital Management LLC” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://theolympiareport.com/2018/02/12/396385-shares-in-catalent-inc-ctlt-acquired-by-hood-river-capital-management-llc.html.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).

Institutional Ownership by Quarter for Catalent (NYSE:CTLT)

Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.